Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast Cancer

Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast Cancer

Targeting the estrogen receptor is an important strategy in breast cancer therapy. However, although inhibiting estrogen receptor function with specific estrogen receptor modulators can achieve a primary response in cancer patients, intrinsic or subsequently acquired resistance to the therapy remai...

Full description

Bibliographic Details
Main Authors: Huajun Zhao, Fu Ou-Yang, I-Fen Chen, Ming-Feng Hou, Shyng-Shiou F. Yuan, Hsueh-Ling Chang, Yi-Chen Lee, Rina Plattner, Susan E. Waltz, Shuk-Mei Ho, Jonathan Sims, Shao-Chun Wang
Format: Article
Language:English
Published: Elsevier 2010-03-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558610801009

Internet

http://www.sciencedirect.com/science/article/pii/S1476558610801009

Similar Items